Jennison Associates
TYRA icon

Jennison Associates’s Tyra Biosciences TYRA Stock Holding History

Jennison Associates’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24.2M Buy
+632,432
New +$20.5M 0.02% 307
2024
Q4 		– Sell
-158,187
Closed -$3.72M – 631
2024
Q3 		$3.72M Buy
158,187
+8,837
+6% +$186K ﹤0.01% 420
2024
Q2 		$2.39M Buy
+149,350
New +$2.57M ﹤0.01% 440
2021
Q4 		– Sell
-468,750
Closed -$8.24M – 729
2021
Q3 		$8.24M Buy
+468,750
New +$8.96M 0.01% 462

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Jennison Associates's TYRA Position: Q1 2026 in Review

Jennison Associates opened a new position in Tyra Biosciences (TYRA) in Q1 2026: 632,432 shares worth $24.2M. The stake represents 0.02% of the portfolio and ranks #307 among its holdings. This is a return to the name: Jennison Associates previously reported a position in TYRA as recently as Q3 2024.

Jennison Associates first reported a position in TYRA in Q3 2021 and has held it in 4 quarters since. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • Jennison Associates held 632,432 shares of Tyra Biosciences worth $24.2M as of Q1 2026.
  • Tyra Biosciences was a new Jennison Associates position in Q1 2026.
  • Tyra Biosciences made up 0.02% of Jennison Associates's portfolio in Q1 2026, its #307 holding.
  • Jennison Associates first reported a position in Tyra Biosciences in Q3 2021 and has held it in 4 quarters since.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Jennison Associates's 13F filing for Q1 2026, filed 6 May 2026.